Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.26
Jul. 16, 2025 16:00:00- Change -0.03 (-2.32558%)
- Volume 291,232
- Today's Open 1.32
- Previous Close 1.29
- Today's High 1.34
- Today's Low 1.2451
- 52 Week High 4.3
- 52 Week Low 0.85